Source: Virtual Congress 2020 – COPD and the impact of comorbidities



Rating:

Share or cite this content

Citations should be made in the following way:
A. Slim (Tunis, Tunisia), H. Kamoun (Tunis, Tunisia), A. Saidane (Tunis, Tunisia), Y. Hdidène (Tunis, Tunisia), H. Ben Abdelghaffar (Tunis, Tunisia), H. Smadhi (Tunis, Tunisia), D. Greb (Tunis, Tunisia), I. Akrout (Tunis, Tunisia), H. Hassene (Tunis, Tunisia), L. Fekih (Tunis, Tunisia), M. Megdiche (Tunis, Tunisia). Impact of diabetes in patients with COPD. 2486

Member's Comments

No comment yet.

Related content which might interest you: Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus Source: International Congress 2017 – COPD management Year: 2017 Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Impact of obesity on pulmonary rehabilitation in COPD patients Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 Impact of diabetes in patients admitted with acute exacerbation of COPD Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Effect of ICS on glycaemic control in patients with COPD and comorbid type 2 diabetes: Historical case-matched cohort study Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Prevalence of comorbidities in patients with COPD in south-Spain Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Risk of development of diabetes mellitus in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 323s Year: 2006 Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Study of microalbuminuria in COPD patients and its association with cardiac comorbidities Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Development of diabetes mellitus in patients with bronchial asthma Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Impact of comorbid bronchiectasis on COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Lung function in the patients with COPD and with the combination COPD and grownup's diabetes Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003 Role of comorbidities in stable COPD patients mortality Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Impact of cardiovascular comorbidities on COPD exacerbations Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 To improvement of diagnostics of the diabetes mellitus 2 type at patients with chronic obstructive pathology of lungs Source: International Congress 2014 – COPD: points to ponder Year: 2014 Death rate of COPD patients and combination with type 2 diabetes Source: Eur Respir J 2007; 30: Suppl. 51, 79s Year: 2007 Assessment of a disease management program for patients with asthma or COPD Source: Eur Respir J 2005; 26: Suppl. 49, 19s Year: 2005 Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus> Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018